We are live on
!
Find out more
FO
FT Options Portfolio holdings
AUM
$66.4M
1-Year Est. Return
18.48%
This Fund
S&P 500
This Quarter
Est. Return
+10.32%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$136M
AUM Growth
–
Cap. Flow
+$524M
Cap. Flow
% of AUM
386.8%
Top 10 Holdings %
Top 10 Hldgs %
40.45%
Holding
204
New
204
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Gilead Sciences
GILD
|
+$13M |
| 2 |
Chipotle Mexican Grill
CMG
|
+$8.2M |
| 3 |
CELG
Celgene Corp
CELG
|
+$6.34M |
| 4 |
CMRX
Chimerix, Inc.
CMRX
|
+$5.55M |
| 5 |
DYAX
DYAX CORPORATION
DYAX
|
+$5.42M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 43.09% |
| 2 | Consumer Discretionary | 6.1% |
| 3 | Materials | 3.81% |
| 4 | Consumer Staples | 3.68% |
| 5 | Technology | 2.76% |
Similar funds
MC
FIM
TLIC
MKCM
ACM
MFM
VE
GFWEV
FT Options's Q4 2015 Portfolio in Review
Q4 2015 is the first quarter with a 13F filing on record for FT Options, which disclosed 204 positions worth $136M. Its ten largest holdings account for 40% of the portfolio.
Its largest position is Gilead Sciences: 125,233 shares worth $12.7M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, followed by Consumer Discretionary and Materials.
- FT Options's largest Q4 2015 buy was Gilead Sciences: 125,233 shares worth $12.7M.
- FT Options's ten largest holdings make up 40% of its $136M portfolio in Q4 2015.
- FT Options disclosed 204 positions in Q4 2015, its first 13F filing on record.
Based on FT Options's 13F filing for Q4 2015, filed 5 Feb 2016.